Lisa Mayr Selected Research

Lisa Mayr Research Topics

Disease

12	Neoplasms (Cancer) 04/2024 - 01/2019
9	Inflammation (Inflammations) 03/2024 - 01/2018
6	Brain Neoplasms (Brain Tumor) 04/2024 - 01/2020
3	Enteritis 03/2024 - 01/2020
3	Virus Diseases (Viral Diseases) 05/2023 - 01/2023
3	Glioma (Gliomas) 12/2022 - 01/2019
3	Weight Loss (Weight Reduction) 06/2022 - 01/2018
3	Osteosarcoma (Osteogenic Sarcoma) 12/2017 - 11/2015
2	Body Weight (Weight, Body) 04/2024 - 01/2018
2	Medulloblastoma 10/2023 - 10/2022
2	Fibrosis (Cirrhosis) 01/2023 - 01/2022
2	Liver Diseases (Liver Disease) 01/2023 - 01/2020
2	Alcoholic Fatty Liver 01/2022 - 01/2018
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2019
2	COVID-19 12/2021 - 08/2020
2	Ependymoma 01/2021 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2018
2	Pathologic Complete Response 01/2020 - 01/2019
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2018 - 01/2018
1	Bacterial Infections (Bacterial Infection) 03/2024
1	Bites and Stings (Sting) 03/2024
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Infections 01/2023
1	Liver Neoplasms (Liver Cancer) 06/2022
1	Fatty Liver 01/2022
1	Hypertrophy 01/2022
1	Insulin Resistance 01/2022
1	Proteinuria 01/2022
1	Central Nervous System Neoplasms 01/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020
1	Multiple Sclerosis 01/2020
1	Crohn Disease (Crohn's Disease) 01/2020
1	Disease Progression 01/2019

Drug/Important Bio-Agent (IBA)

5	Ethanol (Ethyl Alcohol)IBA 01/2023 - 01/2018
3	CytokinesIBA 06/2022 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2019
2	Bevacizumab (Avastin)FDA Link 04/2024 - 01/2023
2	Histones (Histone)IBA 12/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 06/2022 - 12/2021
2	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2022
2	Fatty Acids (Saturated Fatty Acids)IBA 06/2022 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
2	ChemokinesIBA 01/2022 - 01/2022
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 12/2017 - 12/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2017 - 11/2015
2	Methotrexate (Mexate)FDA LinkGeneric 12/2017 - 11/2015
1	AlbuminsIBA 04/2024
1	Serine (L-Serine)FDA Link 03/2024
1	AntioxidantsIBA 03/2024
1	JNK Mitogen-Activated Protein KinasesIBA 01/2023
1	MTOR InhibitorsIBA 01/2023
1	NADPH Oxidase 4IBA 01/2023
1	Interleukin-11 (Interleukin 11)IBA 01/2023
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2022
1	X-Box Binding Protein 1IBA 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	EpitopesIBA 01/2022
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2022
1	CreatinineIBA 01/2022
1	ElectrolytesIBA 01/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	LigandsIBA 01/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	IntegrinsIBA 01/2022
1	Type 4 Fibroblast Growth Factor ReceptorIBA 01/2022
1	InterferonsIBA 12/2021
1	NeopterinIBA 12/2021
1	entrectinibIBA 12/2020
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 08/2020
1	LipopolysaccharidesIBA 01/2020
1	LipidsIBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2020
1	nasIBA 01/2020
1	Biological FactorsIBA 01/2020
1	Dimethyl FumarateIBA 01/2020
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2020
1	NAD (NADH)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	YK 4-279IBA 01/2019
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	TunicamycinIBA 01/2018
1	NoxaeIBA 01/2018

Therapy/Procedure

9	Therapeutics 05/2023 - 12/2017
6	Drug Therapy (Chemotherapy) 01/2023 - 11/2015
2	Precision Medicine 08/2023 - 01/2020
2	Bariatric Surgery 06/2022 - 01/2018
1	Ventriculoperitoneal Shunt 10/2023
1	Organ Transplantation 01/2023
1	Critical Care (Surgical Intensive Care) 12/2021
1	Combined Modality Therapy 12/2020
1	Radiotherapy 01/2020
1	Hematopoietic Stem Cell Transplantation 01/2020